Aushon BioSystems

About:

Aushon BioSystems provides robust protein biomarker assay development, detection and analysis through multiplex immunoassay platform.

Website: http://www.aushon.com

Twitter/X: aushonbio

Top Investors: North Bridge Venture Partners & Growth Equity, ABS Ventures

Description:

Aushon BioSystems provides comprehensive and robust protein biomarker assay development, detection and analysis through an innovative, cost-effective multiplex immunoassay platform that delivers exceptional performance, quality and reliability to accelerate pre-clinical and clinical biomarker research. With a growing menu of more than 300 biomarkers in key therapeutic areas, and advanced microarray printing technology, their broad suite of products and services offers a unique and complete solution for their customers – global leaders in the pharmaceutical, biotechnology, academic and diagnostic industries. They trust us to provide the most reliable protein biomarker data available, in the least amount of time, to lower their costs and improve research productivity.

Total Funding Amount:

$37.4M

Estimated Revenue Range:

$100M to $500M

Headquarters Location:

Billerica, Massachusetts, United States

Founded Date:

2003-06-01

Contact Email:

info(AT)aushon.com

Founders:

Peter Honkanen

Number of Employees:

11-50

Last Funding Date:

2016-07-28

IPO Status:

Private

Industries:

© 2025 bioDAO.ai